Back to the main directory
EarningsReview / Equity
- 杰克股份（603337 CH） by HSBC
- Itaú BBA on São Martinho: 3FQ25 – In-Line Quarter; Still Waiting For Clearer Signs On Commodity Prices by Itau
- Pre Close call Q4: No change in trends by BNP Paribas Exane
- Bradesco (BBDC4 BZ) by HSBC
- M&S and Next progress, Ahold, Dunelm, Fielmann previews +more by HSBC
- In-line performance, hospitals segment driving earnings growth by BNP Paribas Exane
- Itaú BBA on BTG Pactual: 4Q24 Matches; ROE Expansion in 2025 by Itau
- Non material data changes by BNP Paribas Exane
- Doosan Bobcat (241560 KS) by HSBC
- Rainbow Children’s Medicare Ltd (RAINBOW IN) by HSBC
- Revenues in-line with December update, guidance unchanged by BNP Paribas Exane
- Persistent Systems Ltd (PSYS IN) by HSBC
- Global IT Services in 2025: picks and shovels in the AI goldrush by BNP Paribas Exane
- Equinor (EQNR NO) by HSBC
- Q4 should be strong, while waiting for the dust to settle by BNP Paribas Exane
- MBLY & Marubeni Launching a Lyft Robotaxi Service in 2026? Hmm… by BNP Paribas Exane
- Improving earnings, raising estimates by BNP Paribas Exane
- FQ2 25 results first take - a mixed bag by BNP Paribas Exane
- Nolato (Buy, TP: SEK65.00) - Q4 signals strength ahead by DnB Markets
- Schibsted (Sell, TP: NOK290.00) - Uninspiring growth by DnB Markets
- XXL ASA (No_rec, TP: NOK) - Some early signs of recovery by DnB Markets
- Catella (Buy, TP: SEK34.00) - Still awaiting more transactions by DnB Markets
- Ncc (Buy, TP: SEK200.00) - Values expected to materialise by DnB Markets
- Bonheur (Buy, TP: NOK310.00) - Below consensus for Q4e by DnB Markets
- Aker Biomarine (Buy, TP: NOK72.00) - More transactions needed by DnB Markets